Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q/A
Source: 0001731122-25-000254
Chunk: 4

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q/A
Chunk 4
---
 BASIC AND DILUTED NET LOSS PER SHARE                                              |     | $                          |       (0.28 | ) |     | $    |      (0.14 | ) |
| WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING - BASIC AND DILUTED |     |                            | 159,993,372 |   |     |      | 64,480,753 |   |

<div align='center'>See accompanying notes to the unaudited condensed consolidated
financial statements.

3

RENOVARO INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(UNAUDITED)</div>

|                                            |     | For the Three Months Ended 
 September 30,              
 2024                       |             |   |     | 2023 |            |   |
|:-------------------------------------------|:----|:---------------------------|------------:|:--|:----|:-----|:-----------|:--|
| Net Loss                                   |     | $                          | (44,212,036 | ) |     | $    | (9,175,028 | ) |
| Other Comprehensive Income (Loss)          |     |                            |             |   |     |      |            |   |
| Foreign Currency Translation, net of taxes |     |                            |   6,468,061 |   |     |      | (34,601    | ) |
| Comprehensive Loss                         |     | $                          | (37,743,975 | ) |     | $    | (9,209,629 | ) |

<div align='center'>See accompanying notes to the unaudited condensed consolidated
financial statements.

4

RENOVARO INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(UNAUDITED)

(as restated)</div>

| June 30, 2023                                                              
 Issuance of preferred stock and warrants in private placement              
 Issuance of preferred stock and warrants for conversion of $2 million note 
 Restricted shares issued for services rendered                             
 Stock-based compensation                                                   
 Net loss                                                                   
 Foreign currency translation adjustment                                    |     | 

# of Series A Preferred Shares |       — 
 280,505 
 280,505 
       — 
       — 
       — 
       — |     | Series A   Preferred Shares Amount |  — 
 28 
 28 
  —